Alzheimer’s Disease Prediction Service (ADPS)

The Alzheimer’s Disease Prediction Service (ADPS) employs an easy smartphone test to predict whether someone is likely to develop Alzheimer’s in the next six years, using data that has shown 94% accuracy. It will be one of the first validated solutions to enter the EU market as a pre-symptomatic biomarker to predict Alzheimer’s risk for people over 50.
Current diagnostic measures of Alzheimer’s Disease are invasive, expensive and time-consuming, and thus have limited use as frontline screening tools. Although experts realise the potential of screening with virtual reality, augmented reality or activity tracking technologies, routine examination is only carried out after symptoms appear and brain damage is already done. Early screening enables prevention and could dramatically reduce future costs of dementia care.
ADPS unites leading academic and industry partners with a focus on computational dementia diagnosis. It involves memory clinics specialsed in data on pre-symptomatic patients – in Dublin, Barcelona, Zurich, Lausanne and Amsterdam.

Are you the owner of this good practice? Contact to update the information displayed here.
Policy Priorities
Digital tools for citizen empowerment and for person-centred care
Academia, Informal caregivers, Nurses, Nursing homes, Patient, Research centres, Specialised physicians
Geographical Scope
European level
Total Budget
Available upon request
People reached
1,000 – 9,999